We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+23.21%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$27.1B
AUM Growth
+$4.43B
Cap. Flow
-$86.6M
Cap. Flow %
-0.32%
Top 10 Hldgs %
21.67%
Holding
2,442
New
109
Increased
1,083
Reduced
1,137
Closed
107

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$40M
2
AGN
Allergan plc
AGN
+$32.5M
3
RTN
Raytheon Company
RTN
+$26M
4
PSA icon
Public Storage
PSA
+$21M
5
ALL icon
Allstate
ALL
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 24.66%
2 Healthcare 14.4%
3 Financials 13.15%
4 Consumer Discretionary 10.5%
5 Communication Services 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
2301
Agenus
AGEN
$276M
$44K ﹤0.01%
+571
New +$34.2K
AMC icon
2302
AMC Entertainment Holdings
AMC
$2.45B
$44K ﹤0.01%
1,026
-994
-49% -$43.5K
MCF
2303
DELISTED
Contango Oil & Gas Co.
MCF
$44K ﹤0.01%
+19,230
New +$47K
LAB icon
2304
Standard BioTools
LAB
$342M
$43K ﹤0.01%
10,698
+119
+1% +$414
VRAY
2305
DELISTED
ViewRay, Inc.
VRAY
$40K ﹤0.01%
17,914
+1,979
+12% +$4.22K
ACGN
2306
DELISTED
Aceragen Inc
ACGN
$38K ﹤0.01%
1,252
+33
+3% +$1.02K
GPOR
2307
DELISTED
Gulfport Energy Corp.
GPOR
$37K ﹤0.01%
34,371
+20,584
+149% +$30.7K
ACRS icon
2308
Aclaris Therapeutics
ACRS
$715M
$35K ﹤0.01%
21,062
+2,496
+13% +$3.34K
AR icon
2309
Antero Resources
AR
$10.9B
$35K ﹤0.01%
13,854
-882,123
-98% -$2.31M
CLSD
2310
DELISTED
Clearside Biomedical
CLSD
$35K ﹤0.01%
1,254
+214
+21% +$6.3K
CBAY
2311
DELISTED
Cymabay Therapeutics
CBAY
$35K ﹤0.01%
10,107
-7,740
-43% -$22.3K
ANH
2312
DELISTED
Anworth Mortgage Asset Corporation
ANH
$35K ﹤0.01%
20,172
-26,514
-57% -$41.1K
RIGL icon
2313
Rigel Pharmaceuticals
RIGL
$723M
$34K ﹤0.01%
1,869
-1,322
-41% -$23.8K
RRD
2314
DELISTED
RR Donnelley & Sons Co.
RRD
$34K ﹤0.01%
28,236
-4,112
-13% -$5.01K
AUD
2315
DELISTED
Audacy, Inc.
AUD
$33K ﹤0.01%
24,095
-40,808
-63% -$57.7K
GERN icon
2316
Geron
GERN
$898M
$31K ﹤0.01%
+14,174
New +$21.2K
JCP
2317
DELISTED
J.C. Penney Company, Inc.
JCP
$31K ﹤0.01%
93,038
-15,716
-14% -$3.98K
MUX icon
2318
McEwen Inc
MUX
$1B
$27K ﹤0.01%
2,707
-2,177
-45% -$20.2K
DO
2319
DELISTED
Diamond Offshore Drilling
DO
$24K ﹤0.01%
94,529
-136,832
-59% -$174K
HMHC
2320
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$23K ﹤0.01%
12,866
+1,075
+9% +$1.73K
HTZ
2321
DELISTED
Hertz Global Holdings, Inc.
HTZ
$23K ﹤0.01%
16,250
-22,686
-58% -$72K
PEI
2322
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$21K ﹤0.01%
1,027
-67
-6% -$1.21K
CMCM
2323
Cheetah Mobile
CMCM
$87.2M
$19K ﹤0.01%
+2,172
New +$25.6K
LTM
2324
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$16K ﹤0.01%
11,222
-315,758
-97% -$889K
VAL
2325
DELISTED
Valaris plc Class A Ordinary Share
VAL
$15K ﹤0.01%
23,541
-111,157
-83% -$62.9K

Similar funds

Aperio Group's Q2 2020 Portfolio in Review

As of Q2 2020, Aperio Group held 2,442 positions worth $27.1B, up 20% from $22.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q2 2020 filing shows 109 new, 1,083 increased, 1,137 reduced and 107 closed positions. Its largest new stake was Arconic Corporation: 1,326,595 shares worth $18.5M. The largest sale was AT&T, an estimated $40M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Aperio Group's largest Q2 2020 buy was Arconic Corporation: 1,326,595 shares worth $18.5M.
  • Aperio Group added most to Amazon in Q2 2020, an estimated $35.6M increase.
  • Aperio Group's biggest Q2 2020 reduction was AT&T, cutting an estimated $40M.
  • Aperio Group fully exited Allergan plc in Q2 2020, selling an estimated $32.5M.
  • Aperio Group's ten largest holdings make up 22% of its $27.1B portfolio in Q2 2020.
  • Aperio Group opened 109 new positions and closed 107 in Q2 2020.
  • Aperio Group's portfolio value rose 20% quarter-over-quarter to $27.1B.

Based on Aperio Group's 13F filing for Q2 2020, filed 13 Aug 2020.